CYSB2500257 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2025-10-01 | | SinoCelltech Ltd | | | view |
CYSB2500259 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2025-10-01 | | SinoCelltech Ltd | | | view |
CYSB2500258 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2025-10-01 | | SinoCelltech Ltd | | | view |
JYSB2500201 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-09-05 | | Bayer Healthcare LLC | | | view |
JYSB2500202 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-09-05 | | Bayer Healthcare LLC | | | view |
JYSB2500200 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-09-05 | | Bayer Healthcare LLC | | | view |
CYSB2500197 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2025-09-02 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2500198 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2025-09-02 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2500195 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原15) | Supplementary Application | 2025-08-29 | | Hualan Biological Engineering Inc | | | view |
CYSB2500196 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原15) | Supplementary Application | 2025-08-29 | | Hualan Biological Engineering Inc | | | view |
CXSB2500146 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | Supplementary Application | 2025-08-20 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2500152 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2025-07-05 | | China Resources Boya Bio-pharmaceutical Group Co Ltd | | | view |
JYSZ2500014 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2025-06-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JYSZ2500017 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2025-06-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JYSZ2500016 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2025-06-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JYSZ2500015 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2025-06-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
JYSB2500082 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500083 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500081 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-03-26 | | Bayer Healthcare LLC | | | view |
JYSB2500026 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |